Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SKINOVATION PHARMACEUTICAL INCFinancial_Report.xls
10-Q - QUARTERLY REPORT ON FORM 10Q FOR THE QUARTER ENDED MARCH 31, 2012 - SKINOVATION PHARMACEUTICAL INCskin_12q1final.htm
EX-31 - PRINCIPAL FINANCIAL OFFICER CERTIFICATION - SKINOVATION PHARMACEUTICAL INCex312.htm
EX-31 - PRINCIPAL EXECUTIVE OFFICER CERTIFICATION - SKINOVATION PHARMACEUTICAL INCex311.htm

Exhibit 32.1



SKINOVATION PHARMACEUTICAL INCORPORATED


CERTIFICATION OF PERIODIC REPORT

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

18 U.S.C. Section 1350


The undersigned executive officer of Skinovation Pharmaceutical Incorporated certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:


a.

the quarterly report on Form 10-Q of Skinovation Pharmaceutical Incorporated for the quarter ended  March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


b.

the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of  Skinovation Pharmaceutical Incorporated.





Date: May 9, 2012



/s/Hugo Rodier

Hugo Rodier

Principal Executive Officer

Principal Financial Officer